Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - dalteparin sodium 2500 iu/ml - solution for injection - 2500 iu/ml - active: dalteparin sodium 2500 iu/ml excipient: sodium chloride water for injection

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - metoclopramide 5 mg/ml - solution for injection - 100 mg/20ml - active: metoclopramide 5 mg/ml

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

pharmacia limited - clindamycin phosphate - pessary - 100 milligram

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - thiopropazate 5mg - tablet - 5 mg - active: thiopropazate 5mg

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - estramustine phosphate 140mg - capsule - 140 mg - active: estramustine phosphate 140mg

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - etynodiol diacetate 0.5mg - tablet - 0.5 mg - active: etynodiol diacetate 0.5mg

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - lincomycin hydrochloride monohydrate 300 mg/ml;   - solution for injection - 300 mg/ml - active: lincomycin hydrochloride monohydrate 300 mg/ml   excipient: benzyl alcohol water for injection

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - disopyramide phosphate 193.2mg;  ;   - modified release tablet - 150 mg - active: disopyramide phosphate 193.2mg    

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - water for injection 100% - irrigation - 100 % - active: water for injection 100%

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - antithymocyte immunoglobulin 50 mg/ml (equine) - concentrate for injection - 250 mg/5ml - active: antithymocyte immunoglobulin 50 mg/ml (equine) excipient: glycine hydrochloric acid sodium hydroxide water for injection - atgam is indicated for the management of allograft rejection, including delay of onset of first rejection episode, in patients who have undergone renal transplantation.